Podcasts about promising

Seventh Parliamentary Oversight Report: Call for Accountability Amid Promising Shifts by Radio Islam

Luxembourg's Smart Investment Strategy Funds In-Space Manufacturing Platforms Bob Zimmerman John Batchelor and Bob Zimmerman discuss Luxembourg's smart investment strategy of using tax dollars as capital to invest in promising space companies. Luxembourg invested in Space Cargo, which, alongside French startup Comat, is developing the "bento box" orbital platform. This platform supports the rewarding cottage industry of manufacturing high-value products in zero or near-zero gravity. 1959

JP Finlay and Mitch Tischler join you from Kansas City with instant reaction to the Commanders' loss to the Chiefs on Monday Night Football. The guys discuss the game's wild start, Washington's missed opportunities and how the game ultimately got away from Washington. The episode ends with a chat where the Commanders go from here before finishing with Game Balls and Goats.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter In this “Ask Me Anything” (AMA) episode, Peter revisits the “proven, promising, fuzzy, noise, nonsense” scale and applies it to a variety of popular topics. He begins with a refresher on what each category represents before classifying a range of interventions based on the strength of their supporting evidence. The conversation spans three main areas: drugs for geroprotection (including GLP-1 receptor agonists, SGLT2 inhibitors, methylene blue, and telomere-lengthening supplements), the use of low-dose aspirin for cardiovascular disease prevention, and strategies to improve muscle mass through optimal protein intake and follistatin gene therapy. This episode provides a clear, evidence-based overview for listeners seeking to understand where these popular health and longevity interventions stand on the spectrum of scientific credibility. If you're not a subscriber and are listening on a podcast player, you'll only be able to hear a preview of the AMA. If you're a subscriber, you can now listen to this full episode on your private RSS feed or our website at the AMA #76 show notes page. If you are not a subscriber, you can learn more about the subscriber benefits here. We discuss: A scale for evaluating scientific claims: proven, promising, fuzzy, noise, or nonsense [1:30]; Strong convictions, loosely held: the mindset that separates great scientists from the rest [7:30]; GLP-1 receptor agonists: are there benefits beyond improving metabolic health and promoting weight loss? [12:45]; GLP-1 drugs and the brain: exploring the potential cognitive benefits [18:45]; GLP-1 drugs and lifespan: examining the evidence for potential geroprotective effects [23:00]; Rapamycin and geroprotection: why it remains in the “promising” category [25:45]; SGLT2 inhibitors and their potential geroprotective effect [27:30]; Methylene blue: examining the evidence of an anti-aging effect [34:45]; Methylene blue's potential neuroprotective effects: limited and inconsistent evidence in humans, and the challenges of dosing and safety [41:15]; Telomeres: what they are, how they relate to aging, and why telomere-lengthening supplements lack credible scientific evidence [43:45]; Does the idea of targeting telomere length to extend lifespan have scientific merit? [50:15]; Low-dose aspirin for cardiovascular disease prevention: weighing its clot-prevention benefits against bleeding risks across different populations [55:00]; Rethinking the protein RDA: why most people need twice the recommended amount for muscle health [1:00:45]; Debunking the protein–cancer myth: why higher protein intake doesn't promote tumor growth [1:06:15]; The biology of follistatin and myostatin, and why follistatin gene therapy has become an emerging topic of interest for muscle growth [1:13:15]; Follistatin gene therapy for muscle growth: state of the evidence in animals and humans, and the technical challenges and regulatory barriers [1:17:00]; Why injectable follistatin is theoretically possible but impractical for real-world use [1:23:15]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube

QOTD: What was the most promising thing about yesterday's Texans' game?

In this week's episode of WSJ's Take On the Week, co-hosts Gunjan Banerji and Telis Demos discuss market speculation, from the recent sputtering in the gold rally to what to expect from this week's Federal Reserve meeting. Next, Apple is reporting earnings this week, but the company saw a bump after a research report was released saying the company saw strong sales with its latest iPhone.  Later, Robinhood has come a long way since the meme stock mania, entering the S&P 500 company earlier this year and knocking on the door of being the largest publicly traded brokerage company. Christian Bolu, a senior analyst at Autonomous Research, joins Telis to dig into how Robinhood has transformed, how it stacks up to its competitors, such as Interactive Brokers, Charles Schwab, Polymarket and even sports betting company FanDuel, and how much more runway the platform has to grow.  This is WSJ's Take On the Week where co-hosts Gunjan Banerji, lead writer for Live Markets, and Telis Demos, Heard on the Street's banking and money columnist, cut through the noise and dive into markets, the economy and finance—the big trades, key players and business news ahead. Have an idea for a future guest or episode? How can we better help you take on the week? We'd love to hear from you. Email the show at takeontheweek@wsj.com. To watch the video version of this episode, visit our WSJ Podcasts YouTube channel or the video page of WSJ.com Further Reading Gold Price Suffers Worst Day in More Than a Decade; Silver, Platinum Drop Apple Stock Hits New Record on Report of Strong iPhone Sales FanDuel Places Opening Bet on Promising but Precarious Prediction Markets NHL Deal With Kalshi, Polymarket Adds to Pressure on Sports-Betting Companies NYSE Owner to Invest Up to $2 Billion in Polymarket Not Your Daddy's Broker: How Robinhood Stacks Up Against Charles Schwab Robinhood Stock Gets a Prediction Market Boost Robinhood Markets to Join the S&P 500 Index For more coverage of the markets and your investments, head to WSJ.com, WSJ's Heard on The Street Column, and WSJ's Live Markets blog. Sign up for the WSJ's free Markets A.M. newsletter.  Follow Gunjan Banerji here and Telis Demos here.  Learn more about your ad choices. Visit megaphone.fm/adchoices

Sonali Basak gives her takeaways from the CPI report and highlights “promising signs” of inflation easing. She also discusses government data collection issues and delays compounding as the shutdown continues, and how the market is turning to private data releases instead, which don't have the whole picture. She thinks the Fed now has room to support the jobs market with multiple rate cuts. However, because of the lack of data, there could be volatility in markets.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

Colonel Newsham Discusses Promising US-Australia Rare Earth Deal and Canberra's Dual Strategy Toward China Grant Newsham with John Batchelor Colonel Grant Newsham discussed the promising US-Australia rare earth deal, noting Australia has vast mining capabilities to provide an alternative to China's dominance. China's threat to use export controls might spur free nations to develop alternative supply chains. Newsham noted Canberra is playing a "neat trick," maintaining a firm defense alliance with the US (AUKUS) while maintaining profitable economic ties with Beijing, reflecting an underlying "softness" toward China. 1698

Colonel Newsham Discusses Promising US-Australia Rare Earth Deal and Canberra's Dual Strategy Toward China Grant Newsham with John Batchelor Colonel Grant Newsham discussed the promising US-Australia rare earth deal, noting Australia has vast mining capabilities to provide an alternative to China's dominance. China's threat to use export controls might spur free nations to develop alternative supply chains. Newsham noted Canberra is playing a "neat trick," maintaining a firm defense alliance with the US (AUKUS) while maintaining profitable economic ties with Beijing, reflecting an underlying "softness" toward China. 1850

Tom Mulcair can be heard every weekday morning at 7:40 on The Andrew Carter Morning Show.

Howard Kurtz on the high-profile theft of valuable jewels from the Louvre museum in Paris, the potential pardon or commutation of Sean “Diddy” Combs by the Trump Administration, and Diane Keaton's lifelong obsession with buying, renovating, and flipping houses. Follow Howie on Twitter: ⁠⁠⁠⁠⁠⁠⁠⁠@HowardKurtz⁠⁠⁠⁠⁠⁠⁠ ⁠⁠⁠⁠⁠⁠⁠For more #MediaBuzz click here Learn more about your ad choices. Visit podcastchoices.com/adchoices

Discover how long-time StartUp Health community member Sen-Jam Pharmaceutical is revolutionizing healthcare through groundbreaking anti-inflammatory solutions that could bridge the critical gap between lifespan and healthspan. In this StartUp Health NOW episode, co-founders Jim and Jackie Iversen share their journey in developing innovative medications targeting inflammation – the hidden culprit behind numerous age-related diseases and conditions The episode highlights their impressive progress, including: - Phase two clinical trials at Duke University - Positive outcomes in COVID patient studies - 60+ patents in their portfolio - Novel approach to alcohol-related inflammation - Promising collaboration with the National Institute of Drug Abuse Intriguingly, their research extends beyond traditional applications, showing potential in enhancing GLP-1 medications and addressing substance use disorders through neuroinflammation reduction. The team's vision shifts healthcare from reactive "sick care" to proactive health solutions, promising more affordable and accessible medications for long-term use. Ready to explore the future of preventative healthcare? Tune in to hear how Sen-Jam's innovations could transform the way we approach aging and chronic illness management. Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world's biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is a benefit of our Health Moonshot PRO Membership. To schedule a call and see if you qualify to join and increase brand awareness through our multi-media storytelling efforts, submit our three-minute application. If you're mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit. » Learn more and apply today. Want more content like this? Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.  

In this bulletin, signs AUKUS is assured, hours before the Prime Minister meets with Donald Trump, dozens of deaths reported in Israeli strikes on Gaza, with allegations of ceasefire breaches on both sides. And in sport, India backs Kohli to bounce back from poor performance in the last ODI.

Despite President Trump declaring the war in Gaza “over,” the situation on the ground is far from certain. Israel has threatened to block some of the humanitarian aid approved in the deal until Hamas fulfills its promise of returning all the bodies of dead hostages. That hasn't deterred the president from promoting himself as a peacemaker. What's motivating his aggressive push to take credit for the deal?The Middle East is just one part of Trump's foreign policy push. Just this week, he agreed to provide $40 billion in relief for Argentina's struggling economy. However, Americans are hoping he narrows his focus to domestic issues. Recent polling shows that concerns about the economy remain top of mind for most, and there are worries that Trump isn't focused enough on reducing inflation. Is the administration running the risk of losing touch with voters?Many of us are trying to reckon with a culture that glorifies the “grind” of constant work. Focusing solely on rest and relaxation is one way of pushing back, but what if you overdo it? In the constant search for balance, one writer shares thoughts on “pruning” our lives to provide room for reflection and real connection.

An industry legend joins us in studio this month. Anthony Graziano, CEO of Integra Realty Resources and longtime member of the prestigious Counselors of Real Estate is here to share his insights on the state of the market — and where opportunity lies.   We'll explore: Promising verticals for Q4 and beyond — manufacturing, multifamily, and more The importance of selective acquisition — and holding on to what you've acquired Why retail will never really go away — and how to make the most of it The #1 piece of advice he'd give an investor today Don't miss this opportunity to hear from one of the most respected real-estate minds in America.

LIVE: Boy Green reacts to a flurry of roster moves by the Jets!Become a supporter of this podcast: https://www.spreaker.com/podcast/boy-green-daily--1753389/support.

Promising signs of improvement across the primary education sector. The Education Review Office has found teachers are seeing more engaged students, and three-quarters of parents report progress since the start of the year. It follows new data showing more new entrants exceeding phonics expectations. President of Auckland Primary Principals' Association Lucy Naylor told Mike Hosking they're also noticing changes in the engagement and attention of children. She says although the curriculum is still new, these are good signs. Naylor told Hosking the new English and maths curriculum is like a springboard for the next round of subject improvements. She says the slower roll out in other areas has been useful for teachers, so they can focus on core subjects first and feel prepared for more changes to come. LISTEN ABOVE See omnystudio.com/listener for privacy information.

The biggest investor in promising businesses in Europe is Saul Klein's venture capital firm, according to new research from Dealroom. He is the name behind many of Britain's fastest-growing tech businesses. So what does he look for in a business? How can UK businesses take on the US tech giants? And what did he learn from being co-founder of LoveFilm, the UK answer to Netflix? Graham Ruddick went to his offices in London to find out... Hosted on Acast. See acast.com/privacy for more information.

It's World Space Week, and we're fueling up the rocket for a tour of some missions and projects that could provide insights into major space mysteries. Astrophysicist Hakeem Oluseyi joins Host Flora Lichtman to celebrate the wonders of space science, from the recently launched IMAP, which will study the solar environment, to the new Vera Rubin Observatory, and big physics projects like LIGO. Plus, the latest in climate tech: MIT Technology Review has published its annual list of climate tech companies that show great promise in work ranging from producing sodium ion batteries to recycling rare earth magnets. Host Ira Flatow talks with climate reporter Casey Crownhart about trends in climate tech and what companies she's excited about.Guests: Dr. Hakeem Oluseyi is an astrophysicist and author of the upcoming book, Why Do We Exist? The Nine Realms of the Universe That Make You Possible, and host of the video podcast “Particles of Thought.”Casey Crownhart is a senior climate reporter for MIT Technology Review based in New York City.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.A new survey from CRB shows that most life sciences companies, particularly smaller biotechs, are not planning new investments in response to tariffs. The majority of manufacturing initiatives in the U.S. made in response to tariffs are coming from big pharma companies. Sky Bioscience's CB1 inhibitor, Nimacimab, showed promising weight-loss results when combined with Wegovy despite falling short of expectations in a mid-stage obesity trial. Amgen will offer its lipid-lowering drug Repatha directly to patients at a 60% discount. Biospace has honored 40 under 40 leaders in biopharma whose achievements reflect the industry's grit and impact. Pfizer beat out two other suitors for a takeover of Metsera. Maplight seeks a $227 million IPO for its neuropsych portfolio.AMT designation is taking its first steps amid uncertain benefits. Pharming's restructuring triggers a 20% reduction in its workforce. Experts are forging new paths to address scalability, cost, and other barriers surrounding cell therapy production.The CDC has adopted ACIP recommendations on chickenpox and COVID-19 vaccines. Stay tuned for upcoming events such as webinars on mRNA medicine, biopharma deregulation, and transforming digital sequences into mRNA.Various job opportunities in the life sciences industry include positions at Sonothera, Eli Lilly and Company, and Amgen.Support the show

The Lakers' second stop in the preseason had the team headed to Northern California as they faced off against the Golden State Warriors at the Chase Center. And the Lakers did come out with a very solid first half without Austin, LeBron, and Luka, as the Lakers held their own against many of the Warriors' key rotation players. But in the third quarter, as more backups came in, the Lakers got outscored 40-25 as even a scrubs' comeback still had them on the losing end of a 111-103 outcome. Tune in as a Tim Tam-eating Gerald, along with Mark (Commodore64), and Legend recap the game, and what worked and didn't work with Gabe Vincent, Jarred Vanderbilt, Dalton Knecht, and Bronny James. They also discuss the Warriors' post-Kuminga situation and what they looked like during the game as well. The Lakers continue their exhibition schedule with a stop in the Bay against the Warriors, and we're ready to discuss on the Lakers Fast Break podcast!Follow @DripShowshop for some awesome sports merchandise!Check out Dodgers baseball on Playback at https://www.playback.tv/thejoesorooxperimentJoe's new game Coreupt is OUT NOW! Wish List it here: https://store.steampowered.com/app/23... Lakers Fast Break now has YouTube memberships! Join today at / @lakersfastbreak and for just $2.99 a month, you get access to LFB badges and emojis, channel page recognition, and more! Check out Stone Hansen on Twitter @report_court, Alfred Ezman @alfredezman, and John Costa's channels: Clutch Talk- / @clutchtalkpod and Lakers Corner- / @lakerscorner and Legend350 on his new channel / @sportslegend2018 Special Deals today from our friends at #temu today at https://temu.to/m/u1samwbo8cc use code: aca785401 and you might save some $$$ at TEMU! Take a look at the line of Kinhank Mini PC's and retro game machines today at https://www.kinhank-retrogame.com?rs_ref=e8NA2Rm2 for some gaming and computing fun from Kinhank! Don't forget to watch the Lakers games with us LIVE at playback.tv/lakersfastbreak and our newest Lakers Fast Break merchandise site is now up at ⁠http://tinyurl.com/yerbtezk check it out! Please Like, Share, and Subscribe to our channel and our social media @lakersfastbreak on Twitter, Instagram, Facebook, Twitch, on BLUESKY at @lakersfastbreak.bsky.social, e-mail us lakersfastbreak@yahoo.com or catch our audio of the Lakers Fast Break today at ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://anchor.fm/lakers-fast-break⁠, Spotify, Apple Podcasts, or your favorite podcast outlet! The views and opinions expressed on the Lakers Fast Break are those of the panelists or guests themselves and do not necessarily reflect the official policy or position of the Lakers Fast Break or its owners. Any content or thoughts provided by our panelists or guests are of their opinion and are not intended to malign any religion, ethnic group, club, organization, company, individual, anyone, or anything. Presented by our friends at ⁠⁠⁠⁠⁠⁠⁠⁠⁠lakerholics.com⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠lakersball.com⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠Pop Culture Cosmos⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠Inside Sports Fantasy Football⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠Vampires and Vitae⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠SynBlades.com⁠⁠⁠⁠⁠⁠⁠⁠⁠, ⁠⁠⁠⁠⁠⁠⁠⁠⁠YouTube's John Mikaelian⁠⁠⁠⁠⁠⁠⁠⁠⁠, the novel Congratulations, You Suck (available at Amazon and Barnes and Noble), ⁠⁠⁠⁠⁠⁠⁠⁠⁠The Happy Hoarder⁠⁠⁠⁠⁠⁠⁠⁠⁠, EmpireJeffTV, and ⁠⁠⁠⁠⁠⁠⁠⁠⁠Retro City Games!

Tony Foley, Emeritus Associate Professor of Economics at Dublin City University; Tanya Ward, Chief Executive of the Children's Rights Alliance; Susanne Rogers, Research and Policy Analyst with Social Justice Ireland; Paul Hosford, Political Editor with the Irish Examiner

Send us a textIn this special episode, we spotlight the Global EdTech Prize 2025 with founder Vikas Pota of T4 Education and six inspiring finalists from around the world.

Podcast growth professionals. If you're presently hosting a podcast, these monetization experts have sent you emails and messages through LinkedIn. Can you trust them? Are they the real deal? Who is footing the bill?

Preview: Dr. Henry Miller celebrates vaccines for dramatically increasing longevity and eradicating diseases like polio. He notes the success of COVID-19 shots and criticizes the NIH for defunding promising mRNA cancer research. 1919

Podcast growth professionals. If you're presently hosting a podcast, these monetization experts have sent you emails and messages through LinkedIn. Can you trust them? Are they the real deal? Who is footing the bill?Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-like-it-s-live--4113802/support.

This episode will expire in 24 hours! Missed an episode? Pick it back up anytime! Want the back catalog? Become a supporter on Patreon! patreon.com/mercuryradio More info about ARTC And Mercury at artc.org/mercury  Follow us on Bluesky @mercury870

Podcast growth professionals. If you're presently hosting a podcast, these monetization experts have sent you emails and messages through LinkedIn. Can you trust them? Are they the real deal? Who is footing the bill?Become a supporter of this podcast: https://www.spreaker.com/podcast/arroe-collins-unplugged-totally-uncut--994165/support.

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.## Immuneering's drug atebimetinib has shown promising results in doubling overall survival in pancreatic cancer patients after nine months. Truist analysts have deemed the results encouraging, although some unknowns remain in the data. Immuneering plans to initiate a registrational trial for atebimetinib later this year. ## In other news, Lilly has halted a mid-stage obesity study for strategic reasons, Harmony has failed a pivotal trial for fragile X syndrome, and the FDA has released guidance to streamline the development of cell and gene therapies. Overall, Immuneering's drug shows potential in improving survival rates for pancreatic cancer patients, with further trials planned for the future.

The new talk of bodybuilding, and the newest Tampa Pro & Texas Pro Champ.Timestamps:00:00:00 Jordan Hutchinson: Intro00:03:32 4 ½ Weeks Out from the Olympia00:07:08 Gyno Surgery Drama and Complications00:16:43 Low-Carb Days and Refeeds with Patrick Tour00:27:14 26-Week Prep Marathon Breakdown00:36:16 Branch Warren's Offseason Wisdom00:43:21 Growing on Low Food and Steps Focus00:50:36 Tournament of Champions Homecoming01:00:06 Classic vs Open: Weight Caps Exposed01:09:12 Neck-and-Neck with Urs at Olympia?01:16:46 Backing Off Quads to Boost Arms01:25:34 Division Switch Struggles01:32:49 P90X Sparks and Early Gains01:38:06 Beginnings01:47:11 Sugar Fairy Confessions01:52:22 Changes That Aided James's Progress01:55:15 Kratom Myths Busted02:01:39 Dropping from 700mg Tren to 260mg02:11:51 Faith's Role in Adversity02:16:39 Bodybuilding's Finance Reality02:18:58 Final Message: Find Your Purpose

Robbie Campo, Campo's Marina, gives his field report

New Knights coach Justin Holbrook says he's looking forward to working with superstar captain Kalyn Ponga next year after meeting with him for the first time on Friday.See omnystudio.com/listener for privacy information.

Overseas markets and stocks are staging a comeback after nearly 20 years of trailing their U.S. counterparts. Artisan International Fund's award-winning Mark Yockey is finding undervalued growth stocks with plenty of room to run.WEALTHTRACK episode 2212, broadcast 09-19-25

Gio Reyna made his long-awaited Borussia Mönchengladbach debut, and it showed exactly why the USMNT need him at the 2026 World Cup. In this video, I break down Reyna's performance in detail, focusing on his decision-making, his “pass first, dribble second” style of play, and how he can continue to develop throughout the season.Alongside Reyna's debut, I also give a full American's Abroad update, including Tim Weah scoring at the Santiago Bernabéu against Real Madrid, Ricardo Pepi scoring a brace, and the latest performances from USMNT's stars making an impact across Europe.Follow Yanks Abroad Social Channels:TikTok - https://www.tiktok.com/@yanksabroadInstagram - https://www.instagram.com/yanksabroadpod/Twitter - https://twitter.com/yanksabroadpod#USMNT #Pochettino #ChristianPulisic #GioReyna #WorldCup #Soccer

Colorado real estate market opportunities are expanding as distressed builders offer properties at steep discounts. Atlas Real Estate VP Mike Hills manages 6,000+ doors across 10 states and reveals how current market conditions create exceptional opportunities for Colorado investors. These market opportunities include 15-25% discounts on builder inventory and multiple recovery signals indicating 2025 market conditions favor strategic investors.

Sign up for our Hormone Replacement Therapy Risk-Free Membership!https://www.alluremedical.com/hrt-membershipNew innovations have been discovered for the vitality of women in menopause.In this episode, Dr. Charles Mok talks about his book “Testosterone: Strong Enough For A Man, Made For A Woman,” and highlights the essential role of testosterone and hormone replacement therapy (HRT) in promoting healthy aging.He explores the benefits of HRT, shares insights into treatments and supplements that have supported women's intimate health over the years, and the use of platelet-rich fibrin (PRF) and hyaluronic acid as safe, sustainable approaches for sexual wellness and libido.Tune in to Inside The Cure Podcast — Promising Treatments for Women's Intimate HealthSubscribe to the podcast and leave a 5-star review!You can also catch this show on our YouTube channel and on all your favorite podcast platforms.Download Dr. Charles Mok's book, “Testosterone: Strong Enough for a Man, Made for a Woman” for free here. https://www.alluremedical.com/books/ Dr. Charles Mok received his medical degree from Chicago College of Osteopathic Medicine, Chicago, Illinois in 1989. He completed his medical residency at Mount Clemens General Hospital, Mt. Clemens, Michigan. He has worked with laser manufacturing companies to improve their technologies; he has performed clinical research studies and has taught physicians from numerous other states. His professionalism and personal attention to detail have contributed to the success of one of the first medical spas in Michigan.LinkedIn: https://www.linkedin.com/in/charles-mok-4a0432114/ Instagram: https://www.instagram.com/alluremedicals/ Website: https://www.alluremedical.com/ YouTube: https://www.youtube.com/@AllureMedical TikTok: https://www.tiktok.com/@alluremedical  Amazon Store: https://www.amazon.com/stores/Dr.-Charles-Mok/author/B0791M9FZQ?ref=ap_rdr&store_ref=ap_rdr&isDramIntegrated=true&shoppingPortalEnabled=true Join the Allure Medical Inner Circle Membership:https://www.alluremedical.com/inner-circle-membership/ 

Today, we have the next episode in our series of sponsored podcasts with highly vetted companies.  I am delighted to connect with Sarah Kennedy, the founder and CEO of Calocurb, a revolutionary product for weight management that became commercialized after 15 years and $30 million of research from the New Zealand government. Calocurb currently sells in five international markets and continues to grow rapidly through channels and geographies.  Sarah is a veterinarian by training and has held several senior executive positions in the agribusiness and food industries. In our conversation today, we explore the science behind Calocurb, the evolutionary mechanisms of satiety, and how Calocurb reduces caloric intake by 18%. We discuss endogenous GLP-1 drugs, highlighting how Calocurb's mechanism of action differs, and examining current research on gender differences in GLP-1 secretion, including their impact on the menstrual cycle and intermittent fasting. Sarah also covers the four core tenets of Calocurb, shares upcoming research that excites her, and explains the key differences between Calocurb and other supplements, like berberine and chromium. This conversation is truly invaluable, so it's worth revisiting. I am excited about Calocurb's potential to support a variety of needs, helping those looking to improve their hunger and satiety mechanisms, and assisting those taking GLP-1 medications who want to reduce their dosage and transition off GLP-1 medications without compromising the long-term results. IN THIS EPISODE, YOU WILL LEARN: How Calocurb began How Calocurb supports those on GLP-1s looking to lower their doses or taper off (in conjunction with their healthcare team) Sarah explains why Calocurb is very safe, and its four to six-hour mode of action.  The three primary use cases for Calocurb, and how it helps to reduce the side effects and costs associated with GLP-1 injections The importance of making lifestyle changes when transitioning off GLP-1 medications How Calocurb stimulates natural GLP-1 receptors, making it easier to manage food cravings during intermittent fasting Sarah shares how Calocurb helped her manage her love-hate relationship with food. How to take Calocurb for optimal effectiveness Sarah outlines Calocurb's four core values.  How Calocurb differs from other supplements Foods that help to reinforce the satiety mechanism Connect with Cynthia Thurlow   Follow on X, Instagram & LinkedIn Check out Cynthia's website Submit your questions to support@cynthiathurlow.com Connect with Sarah Kennedy Calocurb  Research Articles: Gastrointestinal delivery of bitter hop extract reduces appetite and food cravings in healthy adult women undergoing acute fasting  New Zealand Bitter Hops Extract Reduces Hunger During a 24h Water  Only Fast Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program   

2 Peter 2:2-22 | Pastor Rick In this Sunday Night in the Café message (2 Peter 2:11–22), Pastor Rick warns that false teachers often arise inside the church looking convincing but proving empty. Promising “freedom” while enslaved to corruption themselves. Using Peter's vivid images (wells without water, clouds without rain), he calls us to discernment: be people who measure every claim by Scripture, test the spirits, and watch for wolves in sheep's clothing. Stay close to Jesus and His Word, rely on the Holy Spirit for wisdom, refuse manipulative hype, and help new believers find solid ground in the truth. Packinghouse's Sunday evening worship service from September 14, 2025. - Rick Cornejo - Monday, September 15, 2025

2 Peter 2:2-22 | Pastor Rick In this Sunday Night in the Café message (2 Peter 2:11–22), Pastor Rick warns that false teachers often arise inside the church looking convincing but proving empty. Promising “freedom” while enslaved to corruption themselves. Using Peter's vivid images (wells without water, clouds without rain), he calls us to discernment: be people who measure every claim by Scripture, test the spirits, and watch for wolves in sheep's clothing. Stay close to Jesus and His Word, rely on the Holy Spirit for wisdom, refuse manipulative hype, and help new believers find solid ground in the truth. Packinghouse's Sunday evening worship service from September 14, 2025. - Rick Cornejo - Monday, September 15, 2025

The Auburn Tigers are off to a 3-0 start — but what does that really tell us? In this episode, we break down the early-season highs and lows. From standout performances on both sides of the ball to areas where Auburn still needs to tighten up, we're giving you a balanced look at what's working and what's still a work in progress. Are the Tigers contenders, or are there cracks beneath the surface? Let's talk about it. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nearly 50,000 cases of the blood vessel cancer called canine hemangiosarcoma are diagnosed each…

The National Security Hour with Blanquita Cullum – Things are heating up in Chile as China eyes control of a new Pacific hub, COPIAPORT-E. Promising eco-friendly infrastructure, green energy, and massive shipping capacity, it raises sharp questions. Will Argentina, Brazil, and neighbors embrace it? Can the U.S. afford to stay sidelined as Beijing expands influence in South America's trade and security landscape?

Oracle's (ORCL) "cloud dreams came true, can the A.I. dream come true?" That's the question Dion Hinchcliffe poses after seeing Oracle's strong earnings and guidance that sent the stock soaring more than 40%. While the company has incredible growth aspirations, Dion says the issue Oracle faces will be reaching into "deep pockets" to ensure that guidance comes true. He notes positives that lay out a bullish road forward, including its cloud products and "diversified" business avenues.======== Schwab Network ========Empowering every investor and trader, every market day. Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – https://twitter.com/schwabnetworkFollow us on Facebook – https://www.facebook.com/schwabnetworkFollow us on LinkedIn - https://www.linkedin.com/company/schwab-network/ About Schwab Network - https://schwabnetwork.com/about

The National Security Hour with Blanquita Cullum – Things are heating up in Chile as China eyes control of a new Pacific hub, COPIAPORT-E. Promising eco-friendly infrastructure, green energy, and massive shipping capacity, it raises sharp questions. Will Argentina, Brazil, and neighbors embrace it? Can the U.S. afford to stay sidelined as Beijing expands influence in South America's trade and security landscape?

The 2025 Low-Carbon Real Estate Exhibition brought together more than 12,500 professionals at the Grand Palais to tackle a common challenge: designing sustainable and desirable living spaces. In this new episode of Com d'Archi, we look back at this rapidly growing event, which enlightens architects on concrete solutions for low-carbon construction.This 4th edition of SIBCA has established itself as a showcase for architectural and construction innovations that support the ecological transition. Wood, recycled aluminum, bio-based or reused materials, health and quality of life as design drivers: the avenues are diversifying and becoming more refined. Architects, developers, engineers, designers, and manufacturers presented their advances and compared their visions in a fruitful dialogue that went beyond the field of real estate alone.From Redman to Care Promotion, SOPREMA to Sybois or CoolRoof, Vitra to inventive start-ups such as Anga, Ostrea, and Le Pavé, the ecosystem revealed its dynamism. The importance given to heritage, with the Grand Palais as a backdrop, also served as a reminder that decarbonization applies at all levels, from historic monuments to new neighborhoods.Despite political turmoil, the sector is proving its ability to mobilize creativity and collective intelligence. For architects, this trade show offers a compendium of inspiring practices and potential partners, all of which are resources for designing resilient, low-carbon spaces that are rich in quality of use. It is an event that confirms that architecture is at the heart of building a desirable future.__This English version was generated using AI with voice cloning, preserving the speaker' timbre and the natural French accent. We are currently testing this technology. Please excuse any imperfections. We are working to improve this system so that we can expand our broadcasts to multiple languages. But our favorite Esther will be back soon in English!Speakers : Anne-Charlotte Depondt Audio production comdarchipodcastImage teaser © Anne-Charlotte Depondt ___If you like the podcast do not hesitate:. to subscribe so you don't miss the next episodes,. to leave us stars and a comment :-),. to follow us on Instagram @comdarchipodcast to find beautiful images, always chosen with care, so as to enrich your view on the subject.Nice week to all of you ! Hébergé par Acast. Visitez acast.com/privacy pour plus d'informations.

While the Roadrunners weren't able to pull the upset against #19 Texas A&M, UTSA sure looked the part against an SEC foe. Winning in the trenches and mostly avoiding penalties, Jeff Traylor feels like his team has the right stuff to compete for a championship. UTSA will have a chance to prove their progression over the offseason this week as they welcome Texas State to the Alamodome for the home opener. Can UTSA avenge last year's awful loss in the I-35 Showdown? 04:20 A&M performance recap 34:08 Listener voicemails 46:03 Previewing the Texas State Bobcats 1:11:00 Score predictions Video: https://youtu.be/9MGWFtoFNK0 Learn more about your ad choices. Visit megaphone.fm/adchoices

Katrina is on a role in this short episode as she discusses the broken model of the "one-hour prophy". Listen as she discusses the dangers of blindly following this model and gives 5 ways to improve the appointments.  Resources: More Fast Facts: https://www.ataleoftwohygienists.com/fast-facts/ Katrina Sanders Website: https://www.katrinasanders.com  Katrina Sanders Instagram: https://www.instagram.com/thedentalwinegenist/ 

View the Show Notes Page for This Episode Become a Member to Receive Exclusive Content Sign Up to Receive Peter's Weekly Newsletter Eric Verdin is a physician-scientist and the CEO of the Buck Institute for Research on Aging whose career has centered on understanding how epigenetics, metabolism, and the immune system influence the aging process. In this episode, Eric traces his scientific journey from studying viruses and histone deacetylases (HDACs) to leading aging research at the Buck Institute, offering insights into how aging impairs immune and nervous system function—including thymic shrinkage, chronic inflammation, and reduced vaccine response—and how these changes impact lifespan. He explores the metabolic underpinnings of aging, such as oxidative stress and insulin and IGF-1 signaling, and he discusses practical tools like zone 2 cardio, ketogenic diets, and GLP-1 drugs. The conversation also covers declining NAD levels with age, the roles of NAD-consuming enzymes such as sirtuins and CD38, and what current NAD-boosting strategies (like NMN, NR, and IV NAD) can and can't accomplish. Eric weighs in on promising longevity interventions including rapamycin, growth hormone for thymic regeneration, and anti-inflammatory therapies, while also examining the promise and limitations of current biological age tests and the potential of combining epigenetic, proteomic, and organ-specific metrics with wearables to guide personalized longevity care. We discuss: Eric's scientific journey from virology to the field of geroscience [2:45]; How dysfunction in the immune system and central nervous system can drive aging throughout the body [5:00]; The role of metabolism and oxidative stress in aging, and why antioxidant strategies have failed to deliver clear benefits [8:45]; Other aspects of metabolism linked to aging: mitochondrial efficiency, fuel utilization, and glucose-modulating drugs [16:30]; How inefficient glucose metabolism drives insulin, IGF-1 signaling, and accelerates aging [21:45]; The metabolic effects of GLP-1 agonists, and the need to move beyond crude metrics like BMI in favor of more precise assessments of metabolic health [27:00]; The case for immune health as a “fifth horseman” [36:00]; How the innate and adaptive immune systems work together to build immune memory [39:45]; Why vaccines lose effectiveness with age: shrinking of the thymus gland and diminished T-cell diversity [44:15]; Exploring growth hormone, thymic regeneration, and the role of exercise in slowing immune aging [48:45]; The challenges of identifying reliable biomarkers for immune function, and the potential of rapamycin analogs to enhance vaccine response in older adults [57:45]; How rapamycin's effects on the immune system vary dramatically by dosage and frequency [1:03:30]; The limitations of mouse models in aging research and the need for cautious interpretation of rapamycin's benefits in humans [1:08:15]; NAD, sirtuins, and aging: scientific promise amid commercial hype [1:15:45]; How CD38 drives age-related NAD decline, influences immune function, and may impact longevity [1:23:45]; How NMN and NR supplementation interact with CD38 and NAD metabolism, and potential risks like homocysteine elevation and one-carbon cycle depletion [1:31:00]; Intravenous NAD: limited evidence and serious risks [1:37:00]; Interleukin-11 (IL-11) as a new target in immune aging, the dual role of chronic inflammation in aging, and the need for better biomarkers to guide interventions [1:43:00]; Biological aging clocks: types of clocks, promise, major limitations, and future outlook [1:48:30]; The potential of proteomics-based aging clocks for detecting organ-specific decline and frailty [2:00:45]; and More. Connect With Peter on Twitter, Instagram, Facebook and YouTube